U.S. flag

An official website of the United States government

NM_206933.4(USH2A):c.4124C>T (p.Ser1375Leu) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Nov 5, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001365783.11

Allele description [Variation Report for NM_206933.4(USH2A):c.4124C>T (p.Ser1375Leu)]

NM_206933.4(USH2A):c.4124C>T (p.Ser1375Leu)

Genes:
USH2A-AS1:USH2A antisense RNA 1 [Gene - HGNC]
USH2A:usherin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q41
Genomic location:
Preferred name:
NM_206933.4(USH2A):c.4124C>T (p.Ser1375Leu)
HGVS:
  • NC_000001.11:g.216196680G>A
  • NG_009497.2:g.231769C>T
  • NM_007123.6:c.4124C>T
  • NM_206933.4:c.4124C>TMANE SELECT
  • NP_009054.6:p.Ser1375Leu
  • NP_996816.3:p.Ser1375Leu
  • NC_000001.10:g.216370022G>A
  • NG_009497.1:g.231717C>T
  • NM_206933.2:c.4124C>T
Protein change:
S1375L
Links:
dbSNP: rs751479180
NCBI 1000 Genomes Browser:
rs751479180
Molecular consequence:
  • NM_007123.6:c.4124C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_206933.4:c.4124C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001562065Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 5, 2024)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV001789625GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely pathogenic
(Mar 13, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Cone responses in Usher syndrome types 1 and 2 by microvolt electroretinography.

Zein WM, Falsini B, Tsilou ET, Turriff AE, Schultz JM, Friedman TB, Brewer CC, Zalewski CK, King KA, Muskett JA, Rehman AU, Morell RJ, Griffith AJ, Sieving PA.

Invest Ophthalmol Vis Sci. 2014 Nov 25;56(1):107-14. doi: 10.1167/iovs.14-15355.

PubMed [citation]
PMID:
25425308
PMCID:
PMC4288141

Prevalence and genetic-phenotypic characteristics of patients with USH2A mutations in a large cohort of Chinese patients with inherited retinal disease.

Gao FJ, Wang DD, Chen F, Sun HX, Hu FY, Xu P, Li J, Liu W, Qi YH, Li W, Wang M, Zhang S, Xu GZ, Chang Q, Wu JH.

Br J Ophthalmol. 2021 Jan;105(1):87-92. doi: 10.1136/bjophthalmol-2020-315878. Epub 2020 Mar 18.

PubMed [citation]
PMID:
32188678
PMCID:
PMC7788223
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001562065.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 1375 of the USH2A protein (p.Ser1375Leu). This variant is present in population databases (rs751479180, gnomAD 0.0009%). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 25425308, 32188678, 34781295; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1056888). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt USH2A protein function with a negative predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV001789625.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Observed with a second variant (phase unknown) in unrelated patients with retinitis pigmentosa in the published literature (Colombo et al., 2018; Gao et al., 2020); Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 25425308, 29940899, 31054281, 34781295, 32188678)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025